Table 5.
Transcripts associated with ethylene-responsive metabolic processes.
| ID | Gene Number | ProbeSet No. | Average SLR change after transfer to hormone-containing medium | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 h | 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | |||
| IAA metabolism, transport, signaling | ||||||||||
| DAO1* | AT1G14130 | 262653_at | −0.34 | 0.17 | −0.26 | −0.03 | −0.50 | −0.82 | −0.59 | −0.17 |
| DAO2* | AT1G14120 | 262608_at | −0.09 | −0.21 | −0.27 | −0.23 | −1.03 | −1.48 | −1.49 | −0.84 |
| GH3.3* | AT2G23170 | 245076_at | −0.36 | 0.98 | −0.14 | −0.17 | 0.16 | 0.48 | 0.30 | 0.82 |
| GH3.6* | AT5G54510 | 248163_at | 0.26 | −0.39 | −0.50 | −0.46 | −1.22 | −0.50 | −0.35 | −0.42 |
| CYP71A13 | AT2G30770 | 267567_at | 0.26 | 0.50 | −0.96 | −0.42 | −0.13 | −0.43 | −0.79 | 0.17 |
| UGT74E2* | AT1G05680 | 263231_at | 0.16 | 0.59 | −0.98 | −1.15 | −2.53 | −2.84 | −2.57 | −1.90 |
| Ethylene Metabolism | ||||||||||
| ACO1* | AT2G19590 | 265948_at | 0.16 | 0.38 | 1.41 | 1.72 | 2.23 | 1.96 | 1.73 | 1.54 |
| ACO2 | AT1G62380 | 260637_at | −0.03 | 0.35 | 0.41 | 0.53 | 1.02 | 1.32 | 1.41 | 1.02 |
| ACO3* | AT1G12010 | 264346_at | 0.04 | 0.24 | 0.72 | 0.80 | 1.56 | 2.49 | 2.30 | 1.48 |
| ACO5 | AT1G77330 | 246390_at | −0.13 | −0.32 | 1.11 | 1.19 | 0.70 | 1.00 | 1.19 | 0.88 |
| ACS11* | AT4G08040 | 255177_at | −0.41 | 0.80 | −0.60 | −0.47 | −0.15 | 0.18 | 0.18 | 0.14 |
| Glucosinolate Metabolism | ||||||||||
| BCAT4* | AT3G19710 | 257021_at | 0.49 | −0.19 | −0.38 | −0.79 | −0.03 | 0.48 | 1.59 | 0.101 |
| CYP81F2* | AT5G57220 | 247949_at | 0.13 | 0.97 | 0.00 | −0.67 | 0.93 | 1.81 | 1.95 | 1.65 |
| CYP83A1* | AT4G13770 | 254687_at | 0.71 | −0.32 | 0.16 | −0.50 | 0.36 | 0.60 | 1.32 | −0.07 |
| CYP83B1 | AT4G31500 | 253534_at | −0.52 | 0.43 | 0.60 | −0.29 | 0.19 | 0.20 | 0.17 | 0.22 |
| SOT18 | AT1G74090 | 260385_at | 0.13 | 0.04 | 0.08 | −0.43 | 0.35 | 0.31 | 0.65 | −0.01 |
| Phenylpropanoid Metabolism | ||||||||||
| General | ||||||||||
| PAL4* | AT3G10340 | 259149_at | −0.07 | 0.28 | −0.43 | −0.37 | −0.69 | −0.56 | −0.78 | −0.60 |
| 4CL3* | AT1G65060 | 261907_at | 0.44 | −0.34 | −0.20 | −0.09 | −0.38 | −0.35 | −0.27 | −0.58 |
| Hydroxycinnamate/lignin metabolism | ||||||||||
| F5H, CYP84A1* | AT4G36220 | 261899_at | −0.14 | −0.50 | 0.01 | −0.39 | −0.38 | −0.67 | −0.35 | −0.85 |
| CCOAMT* | AT1G67980 | 260015_at | −0.17 | 1.40 | −0.40 | 0.48 | 1.20 | 2.31 | 2.08 | 2.76 |
| CCOAOMT7* | AT4G26220 | 253985_at | 0.20 | −0.44 | 0.47 | 0.63 | 0.48 | 0.82 | 1.00 | 0.25 |
| ALDH2C4* | AT3G24503 | 258140_at | −0.02 | 0.51 | 0.38 | 0.48 | 0.80 | 0.37 | 0.52 | 0.29 |
| OMT1 | AT5G54160 | 248200_at | 0.08 | 0.06 | 0.60 | 0.68 | 0.78 | 0.72 | 0.73 | 0.27 |
| Flavonoid | ||||||||||
| CHI* | AT2G43570 | 260568_at | 0.12 | 0.78 | −0.78 | −0.28 | 0.37 | 0.09 | 0.12 | 1.02 |
| F3H* | AT3G51240 | 252123_at | 0.44 | −0.60 | −0.34 | 0.00 | −0.48 | −0.26 | −0.03 | −0.73 |
| F3’H* | AT5G07990 | 250558_at | 0.64 | −0.72 | −0.22 | −0.26 | −0.58 | −0.65 | −0.46 | −1.15 |
| FLS1 | AT5G08640 | 250533_at | 0.60 | −0.48 | −0.23 | 0.07 | −0.08 | −0.03 | 0.18 | −0.67 |
| UGT71C3* | AT1G07260 | 256053_at | 0.02 | 0.16 | 0.14 | 0.18 | 0.38 | 0.79 | 1.16 | 0.88 |
| Lipid Metabolism | ||||||||||
| Fatty acid metabolism | ||||||||||
| ACC2* | AT1G36180 | 256459_at | 0.41 | −0.13 | −0.20 | −0.19 | −0.52 | −0.57 | −0.75 | −0.62 |
| Phosphatidylcholine metabolism | ||||||||||
| PLDEPSILON | AT1G55180 | 259657_at | 0.09 | 0.16 | −0.25 | 0.12 | −0.10 | 0.04 | −0.07 | −0.64 |
| PLDGAMMA1* | AT4G11850 | 254847_at | 0.24 | 0.87 | 0.12 | 0.12 | 0.64 | 0.72 | 0.84 | 0.73 |
| PLDDELTA | AT4G35790 | 253120_at | 0.01 | −0.02 | −0.07 | −0.34 | −0.87 | −0.51 | −0.60 | −0.45 |
| NPC4, NPC5* | AT3G03540 AT3G03530 | 259221_s_at | 0.31 | −0.19 | −0.33 | −0.39 | −0.47 | −0.98 | −1.17 | −1.46 |
| PLP1, AtPLAIVA* | AT4G37070 | 246252_s_at | 0.07 | 0.45 | 0.10 | −0.64 | −0.92 | −0.43 | −0.75 | −0.43 |
Shown are genes having average log two-fold values relative to time-matched controls of ≥ 0.5 or ≤ −0.5 (~1.4 or −1.4-fold differences) in all three biological replicates at one or more sampling times (data from 11,12), with values meeting these criteria shown in bold and are underlined. Positive values indicate elevated levels and negative values indicate reduced levels relative to untreated controls. The full list of genes examined for each class with values for each biological replicate are provided in Datafile S5. Asterisks identify genes that meet the criteria for change in response to both auxin and ethylene. Enzyme abbreviations are as defined for Table 4.